42 filings
Page 2 of 3
8-K
1tmv1qwc
21 Feb 23
Dermata Therapeutics Provides Corporate Update and Reports Full Year 2022 Financial Results
4:10pm
8-K
ueym5s0 j4
8 Feb 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
q1wfzzks0b4ndkecsyk5
15 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
0xgkzcwr971zy9jy
5 Dec 22
Dermata Announces Topline Results from DMT310 Phase 2 Clinical Trial for the Treatment of Moderate-to-Severe Rosacea
9:01am
8-K
vozy5f0h4zl8w1e6yx8e
10 Nov 22
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results
5:22pm
8-K
vm1lcmx5xpm
23 Sep 22
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
0fwkbydvu
15 Aug 22
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results
4:20pm
8-K
ej9cgp udy8urgqqfb
11 Jul 22
Amendments to Articles of Incorporation or Bylaws
5:10pm
8-K
excde oz5533
24 Jun 22
Departure of Directors or Certain Officers
5:00pm
8-K
2w937xn7xgssrh1xo
22 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:08pm
8-K
iauvk7
17 May 22
Other Events
4:07pm
8-K
wplbt bd7kfv
16 May 22
Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results
4:09pm
8-K
yv8e1earfusu a8s
25 Apr 22
Dermata Therapeutics Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
4:45pm
8-K
owgx0htzlx1
28 Mar 22
Dermata Therapeutics Provides Corporate Update and Reports Full Year 2021 Financial Results
8:34am
8-K
ciafh1butsklg 9zd
2 Mar 22
Other Events
5:25pm
8-K
vgpih1oli cq30zl
4 Feb 22
Other Events
4:46pm
8-K
wixsj7 f3eo1ve6
13 Jan 22
Dermata Appoints Life Science Executive Brittany Bradrick to Board of Directors
8:30am
8-K
adfg1khhxazpnx yp
10 Dec 21
Departure of Directors or Certain Officers
2:01pm
8-K
juhxc3mfqorfgbbu bx
19 Nov 21
Dermata Announces Positive Results from DMT410 Phase 1b Proof of
9:06am
8-K
4sqt3xj1og 2aq0ru8n
15 Nov 21
Dermata Therapeutics, Inc. Reports Third Quarter 2021
12:00am